426 related articles for article (PubMed ID: 28343365)
1. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
Mazoujian G
Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
[TBL] [Abstract][Full Text] [Related]
3. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
Wong TY; Suster S; Cheek RF; Mihm MC
Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
[TBL] [Abstract][Full Text] [Related]
4. Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers.
Sellheyer K
J Cutan Pathol; 2015 Feb; 42(2):90-101. PubMed ID: 25354097
[TBL] [Abstract][Full Text] [Related]
5. Papillary hidradenoma of the eyelid margin: clinical and immunohistochemical observations further supporting an apocrine rather than an eccrine origin.
Jakobiec FA; Rai R; Lefebvre DR
Surv Ophthalmol; 2014; 59(5):540-7. PubMed ID: 24661803
[TBL] [Abstract][Full Text] [Related]
6. Staining of eccrine and apocrine neoplasms and metastatic adenocarcinoma with IKH-4, a monoclonal antibody specific for the eccrine gland.
Ishihara M; Mehregan DR; Hashimoto K; Yotsumoto S; Toi Y; Pietruk T; Mehregan AH; Mehregan DA
J Cutan Pathol; 1998 Feb; 25(2):100-5. PubMed ID: 9521499
[TBL] [Abstract][Full Text] [Related]
7. The expression of CD23 in cutaneous non-lymphoid neoplasms.
Carvalho J; Fullen D; Lowe L; Su L; Ma L
J Cutan Pathol; 2007 Sep; 34(9):693-8. PubMed ID: 17696916
[TBL] [Abstract][Full Text] [Related]
8. Sox10 and DOG1 Expression in Primary Adnexal Tumors of the Skin.
Lezcano C; Ho J; Seethala RR
Am J Dermatopathol; 2017 Dec; 39(12):896-902. PubMed ID: 28394798
[TBL] [Abstract][Full Text] [Related]
9. Stage-Specific Embryonic Antigen-4 (SSEA-4) as a Distinguishing Marker between Eccrine and Apocrine Origin of Ducts of Sweat Glands.
Borowczyk-Michalowska J; Zimolag E; Konieczny P; Chrapusta A; Madeja Z; Drukala J
J Invest Dermatol; 2017 Nov; 137(11):2437-2440. PubMed ID: 28736232
[No Abstract] [Full Text] [Related]
10. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
Ansai S; Koseki S; Hozumi Y; Kondo S
Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
[TBL] [Abstract][Full Text] [Related]
11. Spiradenoma and dermal cylindroma: comparative immunohistochemical analysis and histogenetic considerations.
Meybehm M; Fischer HP
Am J Dermatopathol; 1997 Apr; 19(2):154-61. PubMed ID: 9129700
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin expression of apocrine and eccrine poromas with special reference to its expression in cuticular cells.
Yamamoto O; Hisaoka M; Yasuda H; Kasai T; Hashimoto H
J Cutan Pathol; 2000 Aug; 27(7):367-73. PubMed ID: 10917164
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity for Sox10 in Basaloid Neoplasms of The Skin.
Bush JW; Gru AA; Wick MR
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):114-118. PubMed ID: 30531326
[TBL] [Abstract][Full Text] [Related]
14. Histochemical and immunohistochemical markers for human eccrine and apocrine sweat glands: an aid for histopathologic differentiation of sweat gland tumors.
Saga K
J Investig Dermatol Symp Proc; 2001 Nov; 6(1):49-53. PubMed ID: 11764285
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical detection of carcinoembryonic antigen and protein S-100 in sweat gland tumors].
Haneke E
Z Hautkr; 1986 Jan; 61(1-2):32-46. PubMed ID: 3513457
[TBL] [Abstract][Full Text] [Related]
16. p53 expression in sweat gland tumors.
Biernat W; Woźniak L
Pol J Pathol; 1996; 47(1):3-6. PubMed ID: 8705267
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity for estrogen receptor protein in sweat gland tumors.
Swanson PE; Mazoujian G; Mills SE; Campbell RJ; Wick MR
Am J Surg Pathol; 1991 Sep; 15(9):835-41. PubMed ID: 1951842
[TBL] [Abstract][Full Text] [Related]
18. KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors.
Nishida H; Daa T; Kashima K; Arakane M; Urabe S; Yoshikawa Y; Gamachi A; Yokoyama S
Am J Dermatopathol; 2015 Dec; 37(12):898-905. PubMed ID: 25634571
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of angiotensin receptors in normal human sweat glands and eccrine poroma.
Takeda H; Kondo S
Br J Dermatol; 2001 Jun; 144(6):1189-92. PubMed ID: 11422040
[TBL] [Abstract][Full Text] [Related]
20. A case of primary signet-ring cell/histiocytoid carcinoma of the eyelid: immunohistochemical comparison with the normal sweat gland and review of the literature.
Iwaya M; Uehara T; Yoshizawa A; Kobayashi Y; Momose M; Honda T; Ota H
Am J Dermatopathol; 2012 Dec; 34(8):e139-45. PubMed ID: 22935888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
